@PeterMacRes
Account based inAustralia!
About this account
- Account based in
- Australia
- Connected via
- Australia App Store
X says this location may be affected by a proxy or VPN.
Account-level information from X, not a live location or the device used for a specific post.
Cancer-dedicated research workforce @PeterMacCC. Committed to better treatments, care and cures for cancer
Parkville, Melbourne, Australia
Joined April 2019
- Tweets2.3K
- Following612
- Followers3.8K
- Likes950
Peter Mac Research retweeted
We’re proud to celebrate Dr Aparna Rao, Dr Deborah Meyran and Associate Professor @SafeeraHussainy, who have been awarded the 2026 Lea Medals.
Read more: petermac.org/about-us/news-a…
Peter Mac Research retweeted
New Peter Mac-led research is changing how we think about breast density.
Not only can it make it harder to interpret mammogram scans, there are signs that dense breasts promote more aggressive #cancer growth.
Read more: petermac.org/about-us/news-a…
Peter Mac Research retweeted
New research at Peter Mac led by A/Prof Annette Lim will investigate which patients are most likely to respond #immunotherapy for head and neck cutaneous squamous cell carcinoma.
This work is funded by the Passe and Williams Foundation.
Read more: petermac.org/about-us/news-a…
Peter Mac Research retweeted
Research led by Peter Mac has found a new way to strengthen cancer-fighting T-cells.
Led by Profs Phil Darcy & @paulbeavis4 (Peter Mac) and A/Prof Jason Waithman (UWA), the study shows boosting the protein Flt3L improves T-cell durability.
Read more: petermac.org/about-us/news-a…
Peter Mac Research retweeted
On 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗗𝗮𝘆 𝗼𝗳 𝗪𝗼𝗺𝗲𝗻 𝗮𝗻𝗱 𝗚𝗶𝗿𝗹𝘀 𝗶𝗻 𝗦𝗰𝗶𝗲𝗻𝗰𝗲, we’re proud to unveil a new exhibition celebrating the women driving life-changing #cancer discoveries - and the real impact their work has on patients’ lives.
#WomenInSTEM #IDWGS
Peter Mac health economist Prof Gang Chen received $1.9M in MRFF funding for a project integrating patient-reported outcomes & preferences into cancer medicine funding decisions.
Focused on breast, melanoma & lung cancer, ALPACA aims to strengthen person-centred health tech.
Haematology registrar @PeterMacCC @eddiecliff has co-authored an important publication reviewing 20 years of RCT for #myeloma. Read more here oncodaily.com/voices/eddie-c…
For #BreastCancerAwarenessMonth, @CureCancerAu is highlighting Dr. Luis Lara Gonzalez.
His work, supported by Cure Cancer, is uncovering how HER2-positive breast cancers resist treatment—& driving more precise, personalised therapies.
More: bit.ly/3IKWVDC
A world-first clinical trial at Peter Mac has found that a simple nasal spray can significantly reduce the risk of COVID-19 in cancer patients. Research published today showed the spray reduced the risk of COVID-19 infection by 40%. Read more here - bit.ly/3JBAjW8
A discovery by researchers at Peter Mac shows that blocking a protein called CDK11 can result in the rapid death of cancer cells - a finding that's described as potentially the 'Achilles' heel of conditions like acute myeloid leukaemia (AML) Read more - bit.ly/4oU3rrI
The 'Faces of Discovery' exhibition is showcasing some of the amazing researchers at Peter Mac to help celebrate National Science Week! The posters are on display in our Welcome Hall and on Level 7 at Peter Mac or you can go to our website to learn more - bit.ly/45ML3JL
Peter Mac Research retweeted
Join Peter Mac’s Research Student Open Day to meet supervisors, chat with students & explore projects.
📅 27 Aug, 4:30pm
📍 Peter MacCallum Cancer Centre
👉 Register now: eventbrite.com.au/e/peter-ma…
Peter Mac Research retweeted
$4.8M in #MRFF funding powers new genomic research at Peter Mac by A/Profs @LEForrest, @DrKaraBritt and Prof Paul James.
More: petermac.org/about-us/news-a…
Peter Mac Research retweeted
Peter Mac trial suggests a way to dramatically improve outcomes in patients with high-risk forms of large B-cell lymphoma.
💊 Standard chemo + new drug glofitamab
✅ 98% complete response
🔒 86% progression-free at ~2 years
📈 92% overall survival
MORE: petermac.org/about-us/news-a…
Peter Mac Research retweeted
Peter Mac’s Prof @MAF_Dawson has won the 2025 @ASH_hematology William Dameshek Prize – the first Australian to receive this top honour for his world-leading work in epigenetics.
More: petermac.org/about-us/news-a…
Peter Mac Research retweeted
Ground-breaking, practice-changing research from Prof Danny Rischin & Prof Sandro Porceddu @PeterMacCC and brilliant team of 🌏investigators. 👏
Excellent results for patients with high-risk SCC of skin, presented at #ASCO25 @ASCO
Full results @NEJM ➡️ nejm.org/doi/full/10.1056/NE…
Peter Mac Research retweeted
A record number of Peter Mac researchers presented at #ASCO25 — with global-impact trials, theranostics leadership, ctDNA breakthroughs & more. 🌍
“Our presence is getting bigger and more impactful each year.” – Prof Jayesh Desai.
Read more: petermac.org/about-us/news-a…
Peter Mac Research retweeted
An experimental therapy involving radioactive Terbium, and designed to seek out and kill prostate cancer cells wherever they are in the body, has shown very positive initial results in a first-in-human clinical trial at Peter Mac.
Read more: petermac.org/about-us/news-a…
#VIOLET Study of Terbium-161 (Tb-161) Beta/Auger therapy @ASCO #ASCO25
First prospective trial of Terbium-161 in any tumour type
🟣 30 patient trial in prostate cancer. No dose limiting toxicities at highest level of radioactivity (7.4 GBq)
🟣 Very few side effects: 1 grade 3 lymphopenia, 1 grade 3 pain exacerbation. No grade 4. No dose delays.
🟣 PSA >90% response in 40%
🟣 Completed >6 months ahead of schedule
ascopubs.org/doi/10.1200/JCO… in press @TheLancetOncol
🟣 Thanks to @ButeauJames @AzadOncology @pj_physics @LouiseKostos @MHaskali
🟣 Funding from @PCF_Science @pros_tic @PeterMacCC
🟣 Terbium-161 PSMA supplied from @Isotopia_Global
Peter Mac Research retweeted
Don't miss the first-in-human VIOLET study being presented #ASCO25 @ASCO
Monday June 2 3:00 PM New Frontiers in Prostate-Specific Membrane Antigen Radioligand Therapy
(awesome research being presented in this session - don't miss the other talks)
In press @TheLancetOncol @ButeauJames @AzadOncology
@PCF_Science @Isotopia_Global @pros_tic
More practice changing research coming out of @PeterMacCC presented @ASCO2025. With a simultaneous publication in @NEJM 🙌
dailynews.ascopubs.org/do/c-…
